267 related articles for article (PubMed ID: 8907906)
1. Impact of different forms of recipient antigen and different routes of antigen administration in donor pretreatment for preventing graft-versus-host disease in rat small bowel transplantation.
He G; Wang M; Xu H; Tian L; Yu J; Stepkowski SM; Kahan BD
Transplant Proc; 1996 Oct; 28(5):2469. PubMed ID: 8907906
[No Abstract] [Full Text] [Related]
2. Donor intrathymic injection with recipient splenocytes allows indefinite survival following small bowel transplantation in a rat graft-vs-host disease model.
Blakely ML; Shaffer D; Ohzato H; Gottschalk R; Van der Werf WJ; Monaco AP
Transplant Proc; 1994 Jun; 26(3):1582. PubMed ID: 8030046
[No Abstract] [Full Text] [Related]
3. Small bowel transplantation in the rat: the effect of donor-specific transfusion 24 hours pretransplant and cyclosporine.
Fecteau A; Tchervenkov J; Guttman FM; Rosenmann E
Transplant Proc; 1992 Jun; 24(3):1166. PubMed ID: 1604571
[No Abstract] [Full Text] [Related]
4. Donor pretreatment with anti-T-cell receptor monoclonal antibodies prevents graft-vs-host disease in brequinar-treated small bowel allograft recipients.
Wang M; Stepkowski SM; Kahan BD
Transplant Proc; 1995 Feb; 27(1):383. PubMed ID: 7879029
[No Abstract] [Full Text] [Related]
5. Amelioration of graft-versus-host disease following bowel transplantation with recipient specific leukocyte transfusion.
Xiao F; Foster PF; Sankary HN; Kociss K; Williams JW
Transplant Proc; 1992 Jun; 24(3):1192-3. PubMed ID: 1604582
[No Abstract] [Full Text] [Related]
6. Irradiation of the donor combined with cyclosporine A treatment of the recipient prevents graft-versus-host disease and leads to prolonged survival of small-bowel allografts.
Saat RE; de Bruin RW; Heineman E; Jeekel J; Marquet RL
Transplant Proc; 1990 Dec; 22(6):2465-6. PubMed ID: 2264111
[No Abstract] [Full Text] [Related]
7. The effect of rapamycin on orthotopic small bowel transplantation in the rat.
Chen H; Wu J; Xu D; Aboujaoude M; Stepkowski S; Kahan B; Daloze P
Transplant Proc; 1992 Jun; 24(3):1157-8. PubMed ID: 1604567
[No Abstract] [Full Text] [Related]
8. Allograft ultraviolet-B irradiation in rat small intestinal transplantation.
Foster PF; Xiao F; Kociss K; Chong AS; Sankary HN; McChesney L; Cohn S; Williams JW
Transplant Proc; 1994 Jun; 26(3):1624-5. PubMed ID: 8030062
[No Abstract] [Full Text] [Related]
9. Evidence for the role of host antigen-presenting cells in the induction of specific unresponsiveness to allografts by intrathymic inoculation of allopeptides.
Oluwole SF; Jin MX; Chowdhury NC; Engelstad K; Ohajekwe OA; Hardy MA
Transplant Proc; 1995 Feb; 27(1):132-3. PubMed ID: 7878898
[No Abstract] [Full Text] [Related]
10. Suppressive effects of serum from liver-transplanted rats against graft-versus-host disease.
Enoki T; Kamada N; Schlect D; Buckley M; Goto S; Hara Y; Shimizu Y; Vari F; Morita N; Esato K
Transplant Proc; 1996 Jun; 28(3):1769-70. PubMed ID: 8658875
[No Abstract] [Full Text] [Related]
11. Comparison of the effectiveness of cyclosporine A in small-bowel transplantation using different rat strain combinations.
Langrehr JM; Lee KK; Wachs ME; Lee TK; Stangl MJ; Venkataramanan R; Kunz HW; Schraut WH
Transplant Proc; 1990 Dec; 22(6):2533-5. PubMed ID: 2264139
[No Abstract] [Full Text] [Related]
12. Fulminant graft-versus-host disease after FK 506 treatment in fully allogeneic small bowel transplantation.
de Bruin RW; HogenEsch H; Heineman E; Jeekel J; Marquet RL
Transplant Proc; 1991 Dec; 23(6):3257-9. PubMed ID: 1721429
[No Abstract] [Full Text] [Related]
13. Role of donor natural killer cells on lethal graft-versus-host disease following small bowel transplantation in the rat.
Okamoto M; Arakawa K; Akioka K; Fujiwara I; Takeshita K; Oka T
Transplant Proc; 1996 Oct; 28(5):2467-8. PubMed ID: 8907905
[No Abstract] [Full Text] [Related]
14. The effect of ultraviolet B-irradiated leukocyte transfusions in intestinal transplantation.
Xiao F; Foster PF; Sankary HN; Kociss K; Templeton AC; Williams JW
Transplant Proc; 1992 Jun; 24(3):1167-8. PubMed ID: 1604572
[No Abstract] [Full Text] [Related]
15. Effect of donor pretreatment on graft-versus-host disease (GVHD) after rat small-bowel transplantation (SBTX).
Matsumoto S; Tanaka S; Orita K
Transplant Proc; 1994 Aug; 26(4):2306-8. PubMed ID: 8066758
[No Abstract] [Full Text] [Related]
16. Induction of tolerance to small bowel allotransplants by mixed allogeneic chimerism.
Orloff MS; Orloff SL; DeMara EM; Coppage ML; Leong N; Fallon MA
Transplant Proc; 1994 Jun; 26(3):1585-6. PubMed ID: 8030048
[No Abstract] [Full Text] [Related]
17. Lethal graft-vs-host disease after cyclosporine therapy in recipients of sensitized small bowel allografts.
Langrehr JM; Markus PM; Lee TK; Müller AR; Banner B; Lee KK; Schraut WH
Transplant Proc; 1992 Jun; 24(3):1138. PubMed ID: 1604556
[No Abstract] [Full Text] [Related]
18. Prevention of graft-versus-host disease after bone marrow and small bowel transplantation by ultraviolet B modulation of bone marrow cells.
Chowdhury NC; Jin MX; Hardy MA; Oluwole SF
Transplant Proc; 1993 Feb; 25(1 Pt 1):475-6. PubMed ID: 8438384
[No Abstract] [Full Text] [Related]
19. Rapamycin graft pretreatment in small bowel and kidney transplantation in the rat.
Chen H; Xu D; Qi S; Wu J; Luo H; Daloze P
Transplantation; 1995 Apr; 59(8):1084-9. PubMed ID: 7732551
[TBL] [Abstract][Full Text] [Related]
20. Effects of preformed antibodies induced by whole blood transfusion on small bowel transplantation.
Fujisaki S; Murase N; Demetris AJ; Tanabe M; Todo S; Starzl TE
Transplant Proc; 1994 Jun; 26(3):1528-9. PubMed ID: 7518140
[No Abstract] [Full Text] [Related]
[Next] [New Search]
